Zaleplon
10 NDCs across 5 manufacturers|10 Generic,0 Brand
Zaleplon is used to treat sleep initiation and maintenance disorders, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Aug 13, 1999, and the first generic was approved Jun 6, 2008. FDA's Orange Book lists 10 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $4 million on Zaleplon across 176,000 claims for 50,000 beneficiaries.
Zaleplon is available as 10 NDCs from 5 manufacturers (10 generic, 0 brand), with NADAC prices from $0.14 to $0.16 per EA — a 11% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
10
10G / 0B
Manufacturers
5
competing in market
Price Spread
$0.14 – $0.16
per EA
7d Activity
avg +4.2% WoW · of 10 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Unichem Pharmaceuticals (USA) Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
gamma-Aminobutyric Acid A Receptor Agonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
5 manufacturers producing ZALEPLON
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ZALEPLON 5 MG CAPSULE | $0.1568 per EA | +8.56% |
ZALEPLON 5 MG CAPSULE | $0.1568 per EA | +8.56% |
ZALEPLON 5 MG CAPSULE | $0.1568 per EA | +8.56% |
ZALEPLON 5 MG CAPSULE | $0.1568 per EA | +8.56% |
ZALEPLON 5 MG CAPSULE | $0.1568 per EA | +8.56% |
ZALEPLON 10 MG CAPSULE | $0.1409 per EA | -0.25% |
ZALEPLON 10 MG CAPSULE | $0.1409 per EA | -0.25% |
ZALEPLON 10 MG CAPSULE | $0.1409 per EA | -0.25% |
ZALEPLON 10 MG CAPSULE | $0.1409 per EA | -0.25% |
ZALEPLON 10 MG CAPSULE | $0.1409 per EA | -0.25% |
Frequently Asked Questions
What is Zaleplon used to treat?
Zaleplon is used to treat sleep initiation and maintenance disorders, per the National Library of Medicine's MED-RT classification.
When did Zaleplon become available as a generic?
FDA approved the first generic Zaleplon (ANDA) on Jun 6, 2008. The Orange Book currently lists 10 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Zaleplon?
In 2024, Medicare Part D spent $4 million on Zaleplon across 176,000 claims for 50,000 beneficiaries.
How many Zaleplon products are on the market?
The Zaleplon drug market contains 10 NDCs from 5 manufacturers — 10 generic and 0 brand products.
What is the price range for Zaleplon?
NADAC reference prices for Zaleplon range from $0.1409 to $0.1568 per EA — a 11% difference between cheapest and most expensive.
Which manufacturers make Zaleplon?
5 manufacturers list Zaleplon in NADAC. Ranked by number of NDCs, the largest are Unichem Pharmaceuticals (USA) Inc. (2), Aurobindo Pharma Limited (2), Rising Pharma Holdings Inc. (2), Bionpharma Inc. (2), Hikma Pharmaceuticals USA Inc. (2).
How has the price of Zaleplon changed recently?
Over the past 7 days, 5 Zaleplon NDCs rose and 5 fell, with a market-wide average change of +4.2%.